{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:56:35Z","timestamp":1791194195412,"version":"4.1.0"},"reference-count":46,"publisher":"National Academy of Sciences","issue":"11","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2010,3,16]]},"abstract":"<jats:p>\n                    Inhibition of blood vessel formation is a viable therapeutic approach in angiogenesis-dependent diseases. We previously used a combinatorial screening on vascular endothelial growth factor (VEGF)-activated endothelial cells to select the sequence CPQPRPLC and showed that the motif Arg-Pro-Leu targets VEGF receptor-1 and neuropilin-1. Here, we evaluated and validated\n                    <jats:sub>D<\/jats:sub>\n                    (LPR), a derivative molecule with strong antiangiogenesis attributes. This prototype drug markedly inhibits neovascularization in three mouse models: Matrigel-based assay, functional human\/murine blood vessel formation, and retinopathy of prematurity. In addition to its systemic activity,\n                    <jats:sub>D<\/jats:sub>\n                    (LPR) also inhibits retinal angiogenesis when administered in an eye-drop formulation. Finally, in preliminary studies, we have showed targeted drug activity in an experimental tumor-bearing mouse model. These results show that drugs targeting extracellular domains of VEGF receptors are active, affect signal transduction, and have potential for clinical application. On a larger context, this study illustrates the power of ligand-directed selection plus retro-inversion for rapid drug discovery and development.\n                  <\/jats:p>","DOI":"10.1073\/pnas.0915141107","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T21:34:17Z","timestamp":1267220057000},"page":"5112-5117","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":64,"title":["From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway"],"prefix":"10.1073","volume":"107","author":[{"given":"Ricardo J.","family":"Giordano","sequence":"first","affiliation":[{"name":"David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Card\u00f3-Vila","sequence":"additional","affiliation":[{"name":"David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Salameh","sequence":"additional","affiliation":[{"name":"David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane D.","family":"Anobom","sequence":"additional","affiliation":[{"name":"National Nuclear Magnetic Resonance Center, Rio de Janeiro Federal University, Rio de Janeiro 21941, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Zeitlin","sequence":"additional","affiliation":[{"name":"Angiogenesis Research Laboratory, University of Michigan School of Dentistry, Ann Arbor, MI 48109;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Hawke","sequence":"additional","affiliation":[{"name":"Center for Targeted Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030;and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Valente","sequence":"additional","affiliation":[{"name":"National Nuclear Magnetic Resonance Center, Rio de Janeiro Federal University, Rio de Janeiro 21941, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio C. L.","family":"Almeida","sequence":"additional","affiliation":[{"name":"National Nuclear Magnetic Resonance Center, Rio de Janeiro Federal University, Rio de Janeiro 21941, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques E.","family":"N\u00f6r","sequence":"additional","affiliation":[{"name":"Angiogenesis Research Laboratory, University of Michigan School of Dentistry, Ann Arbor, MI 48109;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Sidman","sequence":"additional","affiliation":[{"name":"Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Pasqualini","sequence":"additional","affiliation":[{"name":"David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadih","family":"Arap","sequence":"additional","affiliation":[{"name":"David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2010,2,26]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197108122850711"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2115"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.062547"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04478"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03203.x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2183"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032691"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-008-0675-8"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042760"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2403"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5287"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2524"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/87904"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm884"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm731"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04186"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0831"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.10.018"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813061106"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.038"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1101-1249"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2005.07.008"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2005.02.009"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.09.018"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/bip.20219"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389203033487054"},{"key":"e_1_3_3_28_2","first-page":"364","volume-title":"Biochemistry of the Amino Acids","author":"Meister A","year":"1965","unstructured":"A Meister Biochemistry of the Amino Acids (Academic, 2nd Ed, New York) 1, 364 (1965).","edition":"2"},{"key":"e_1_3_3_29_2","first-page":"519","article-title":"A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor","volume":"67","author":"Passaniti A","year":"1992","unstructured":"A Passaniti, et al., A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67, 519\u2013528 (1992).","journal-title":"Lab Invest"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780253"},{"key":"e_1_3_3_31_2","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith LE","year":"1994","unstructured":"LE Smith, et al., Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35, 101\u2013111 (1994).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.3.905"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.181329198"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/08820530902800314"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611492104"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607542104"},{"key":"e_1_3_3_37_2","first-page":"2337","article-title":"Retinal vascular permeability suppression by topical application of a novel VEGFR2\/Src kinase inhibitor in mice and rabbits","volume":"118","author":"Scheppke L","year":"2008","unstructured":"L Scheppke, et al., Retinal vascular permeability suppression by topical application of a novel VEGFR2\/Src kinase inhibitor in mice and rabbits. J Clin Invest 118, 2337\u20132346 (2008).","journal-title":"J Clin Invest"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.02.042"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201545"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511941200"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.08.005"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-107219"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0908201106"},{"key":"e_1_3_3_44_2","first-page":"79","article-title":"Genetic dissection of tumor angiogenesis: Are PlGF and VEGFR-1 novel anti-cancer targets?","volume":"1654","author":"Luttun A","year":"2004","unstructured":"A Luttun, M Autiero, M Tjwa, P Carmeliet, Genetic dissection of tumor angiogenesis: Are PlGF and VEGFR-1 novel anti-cancer targets? Biochim Biophys Acta 1654, 79\u201394 (2004).","journal-title":"Biochim Biophys Acta"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2531"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmra.1993.1098"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.0915141107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T19:21:24Z","timestamp":1649791284000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.0915141107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,26]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,3,16]]}},"alternative-id":["10.1073\/pnas.0915141107"],"URL":"https:\/\/doi.org\/10.1073\/pnas.0915141107","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,26]]},"assertion":[{"value":"2010-02-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}